Literature DB >> 8291656

Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens.

F M Lai1, K N Lai, J S Tam, S F Lui, K F To, P K Li.   

Abstract

The glomerular pathology and hepatitis B virus (HBV) antigens in renal biopsies were investigated in 100 consecutive patients with both primary glomerulonephritis and positive serology for hepatitis B surface antigen (HBsAg). Glomerular HBV antigens including HBsAg, hepatitis B core antigen (HBcAg), and hepatitis B e antigen (HBeAg) were examined in frozen tissue using both polyclonal and monoclonal antibodies. HBV serology and glomerular antigens were correlated. Using monoclonal antibodies, at least one of the three HBV antigens was detectable in glomeruli in 39% of the cases. These findings correspond mainly to detectable glomerular HBsAg and HBeAg in 22.3 and 28.4% of cases, respectively. A good correlation was found between glomerular and serum HBeAg but not observed for HBsAg. Serum HBcAg was not examined and not correlated with glomerular staining. When the diagnosis of HBV-related glomerulonephritis was based strictly on detectable glomerular antigens, three distinctive morphologies were identified: membranous nephropathy, mesangiocapillary glomerulonephritis, and mesangial proliferative glomerulonephritis with immunoglobulin A (IgA) deposits (IgA nephropathy). Each of these lesions may be seen in pure form or occasionally in overlapping form leading to double glomerulopathies. Glomerular HBeAg and HBsAg were associated with subepithelial and mesangial immune complexes, respectively. Rare overlap between membranous nephropathy and IgA nephropathy further emphasized the distinctive pathology of HBV-related glomerulonephritis and the independent etiological role of HBeAg and HBsAg. In other glomerulonephritis, which rarely demonstrated glomerular HBV antigens, the pathogenetic role of chronic HBV infection remains to be proven.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8291656     DOI: 10.1097/00000478-199402000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  Extrahepatic manifestations of chronic viral hepatitis.

Authors:  N T Pyrsopoulos; K R Reddy
Journal:  Curr Gastroenterol Rep       Date:  2001-02

2.  Anti-phospholipase A2 receptor antibody in membranous nephropathy.

Authors:  Weisong Qin; Laurence H Beck; Caihong Zeng; Zhaohong Chen; Shijun Li; Ke Zuo; David J Salant; Zhihong Liu
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

3.  Interferon treatment in hepatitis B virus-associated membranous glomerulopathy.

Authors:  S Kavukçu; G Başdemir; Y Eroğlu; M Türkmen; F Eser; B Büyükgebiz
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

4.  Impact of posttransplantation glomerulonephritis on long-term outcome of kidney transplants: single-center 20-year experience.

Authors:  Tung-Min Yu; Mei-Chin Wen; Ming-Ju Wu; Cheng-Hsu Chen; Chi-Hung Cheng; Chi-Yuan Li; Kuo-Hsiung Shu
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

Review 5.  Infection and glomerulonephritis.

Authors:  Saraladevi Naicker; June Fabian; Sagren Naidoo; Shoyab Wadee; Graham Paget; Stewart Goetsch
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

6.  Membranous nephropathy associated with gastrointestinal stromal tumour: a case report.

Authors:  Adela Cimic; Stephen O Pastan; Vanesa Bijol
Journal:  NDT Plus       Date:  2009-03-04

Review 7.  Viral nephropathy.

Authors:  Andrew S H Lai; Kar Neng Lai
Journal:  Nat Clin Pract Nephrol       Date:  2006-05

Review 8.  How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy.

Authors:  Tiffany N Caza; Laith F Al-Rabadi; Laurence H Beck
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

Review 9.  Hepatitis B-Associated Lupus-Like Glomerulonephritis Successfully Treated With Antiretroviral Drugs and Prednisone: A Case Report and Literature Review.

Authors:  Sasmit Roy; Rohan Gupta; Sreedhar Adapa; Subhashish Bose; Amarinder Garcha
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

10.  Clinicopathological features, risk factors, and outcomes of immunoglobulin A nephropathy associated with hepatitis B virus infection.

Authors:  Kailong Wang; Zhikai Yu; Yinghui Huang; Ke Yang; Ting He; Tangli Xiao; Yanlin Yu; Yan Li; Liang Liu; Jiachuan Xiong; Jinghong Zhao
Journal:  J Nephrol       Date:  2021-03-08       Impact factor: 3.902

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.